Scholar Rock Holding (SRRK) Enterprise Value (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Enterprise Value of -$479.9 million in Q1 2026, down 30.57% quarter-over-quarter from -$367.6 million in Q4 2025, and down 31.72% on a YoY basis from -$702.9 million in Q1 2025.

Scholar Rock Holding (SRRK) Enterprise Value (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Enterprise Value history runs 10 years deep, the most recent figure standing at -$479.9 million for Q1 2026.

  • In Q1 2026, Enterprise Value fell 31.72% year-over-year to -$479.9 million; the TTM figure through Mar 2026 stood at -$479.9 million (down 31.72% YoY), while the FY2025 annual figure was -$367.6 million, up 15.94% from the prior year.
  • Enterprise Value was -$479.9 million for Q1 2026 at Scholar Rock Holding, down from -$367.6 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$139.1 million in Q3 2024 to a low of -$479.9 million in Q1 2026.
  • Historically, Enterprise Value has averaged -$302.6 million across 5 years, with a median of -$295.0 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 36.39% in 2024, then plunged 165.8% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$315.4 million in 2022, then climbed by 11.23% to -$279.9 million in 2023, then slumped by 56.21% to -$437.3 million in 2024, then increased by 15.94% to -$367.6 million in 2025, then plunged by 30.57% to -$479.9 million in 2026.
  • The last three Enterprise Value figures came in at -$479.9 million (Q1 2026), -$367.6 million (Q4 2025), and -$369.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -4.14 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -7.20 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -7.25 Bn
9 Abivax 91.96 Bn 91.96 Bn - -584.73 Mn
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - -479.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -479.94 Mn
Dec 31, 2025 -367.56 Mn
Sep 30, 2025 -369.63 Mn
Jun 30, 2025 -295.01 Mn
Mar 31, 2025 -364.38 Mn
Dec 31, 2024 -437.28 Mn
Sep 30, 2024 -139.07 Mn
Jun 30, 2024 -190.49 Mn
Mar 31, 2024 -238.43 Mn
Dec 31, 2023 -279.94 Mn
Sep 30, 2023 -218.64 Mn
Jun 30, 2023 -248.73 Mn
Mar 31, 2023 -275.28 Mn
Dec 31, 2022 -315.36 Mn
Sep 30, 2022 -343.66 Mn
Jun 30, 2022 -370.69 Mn
Mar 31, 2022 -210.21 Mn
Dec 31, 2021 -252.99 Mn
Sep 30, 2021 -246.44 Mn
Jun 30, 2021 -282.22 Mn